Monoclonal Gammopathy of Undetermined Significance (MGUS)

specific

Centers

Active Trials

$29M

Cancer Funding

Top Centers for Monoclonal Gammopathy of Undetermined Significance (MGUS)(8)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	$6M	86.9
2	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	—	$6M	68.8
3	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	—	$6M	60.0
4	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive Active Research Program	Active Research Program	—	$4M	55.6
5	O’Neal Comprehensive Cancer Center at the University of Alabama at BirminghamBirmingham, AL NCI Comprehensive Active Research Program	Active Research Program	—	$4M	51.3
6	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	—	$3M	46.9
7	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	—	$1M	42.5
8	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program	Active Research Program	—	$846K	38.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →